BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37775376)

  • 1. Surgical resection of late-stage hepatocellular carcinoma for patients having undergone combined HAIC, targeted and immunotherapy.
    Sun R; He Q; Pan L; Huang P
    Asian J Surg; 2024 Jan; 47(1):523-524. PubMed ID: 37775376
    [No Abstract]   [Full Text] [Related]  

  • 2. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
    Lee BH; Lee DS; Cho CW; Yun SS
    World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H
    Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination Therapy of Hepatic Arterial Infusion Chemotherapy and Surgical Resection against Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis].
    Kimura Y; Tokumitsu Y; Matsukuma S; Matsui H; Shindo Y; Nakajima M; Yoshida S; Iida M; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Hazama S; Ueno T; Nagano H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):760-762. PubMed ID: 31164527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
    Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
    Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
    Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
    Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
    Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
    World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver resection after downstaging with systemic chemotherapy in a case of a multicentric hepatocellular carcinoma with virus B cirrhosis].
    Ionescu M; Dumitraşcu T; Stroescu C
    Chirurgia (Bucur); 2007; 102(3):337-43. PubMed ID: 17687865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese approach to hepatocellular carcinoma.
    Torzilli G
    Dig Liver Dis; 2001 Mar; 33(2):118-20. PubMed ID: 11346136
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review.
    Walter H; Thomas AL
    Br J Cancer; 2013 Jun; 108(12):2417-8. PubMed ID: 23801031
    [No Abstract]   [Full Text] [Related]  

  • 13. Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis.
    Hu L; Zheng Y; Lin J; Shi X; Wang A
    World J Surg Oncol; 2023 Apr; 21(1):121. PubMed ID: 37013589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic chemotherapy of hepatocellular carcinoma].
    Okazaki N; Yoshino M; Yoshida T; Hizikata A; Hasegawa H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1584-8. PubMed ID: 3015033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation?
    Bismuth H; Chiche L; Adam R; Castaing D
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1066-7. PubMed ID: 8382848
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib combined with locoregional therapy prior to liver transplantation for hepatocellular carcinoma: an update on a previous case report.
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2013 Jun; 44(2):246-7. PubMed ID: 22815137
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
    Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.